Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - MISONIX INCs104792_ex99-1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 28, 2016

 

MISONIX, INC.

(Exact name of Registrant as specified in its charter)

 

New York
(State or other jurisdiction
of incorporation)
1-10986
(Commission File Number)
11-2148932
(I.R.S. Employer
Identification No.)

 

1938 New Highway, Farmingdale, New York 11735

(Address of principal executive offices, including zip code)

 

(631) 694-9555

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

Item 8.01. Other Events

 

On November 28, 2016, Misonix, Inc. (the “Company”) issued a press release announcing the acceptance by the Nasdaq Stock Market LLC (“Nasdaq”) of the Company's plan to regain compliance with Nasdaq listing rule 5250(c)(1), which would permit the continued listing of the Company’s common stock on the Nasdaq Global Market. Under the terms of the exception, the Company must file its delinquent Forms 10-K and 10-Q on or before March 13, 2017. In the event that Misonix does not satisfy the terms set forth in the extension, Nasdaq will provide written notification that the Company’s common stock will be delisted. At that time, the Company may appeal Nasdaq's determination for a panel review.

 

The aforementioned press release is attached hereto as Exhibit 99.1.

 

Item 9.01. Financial Statements and Exhibits

 

(d)       Exhibits

 

Exhibit No.       Description of Exhibit

 

99.1                   Press Release dated November 28, 2016

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MISONIX, INC.
   
Date: November 28, 2016 By: /s/ Stavros G. Vizirgianakis
    Stavros G. Vizirgianakis
    Interim Chief Executive Officer

 

 3